11 High Growth Micro-cap Stocks to Buy

Page 2 of 10

9. Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Number of Hedge Fund Holders: 15

Market Capitalization: $135.08 million

5-year Revenue Growth: 39.65%

Treace Medical Concepts is one of the high-growth micro-cap stocks to buy. On January 7, Stifel lowered its price target on Treace Medical Concepts, Inc. (NASDAQ:TMCI) to $3 from $5 while maintaining a Hold rating, reflecting a broader recalibration across its MedTech coverage following the pressures seen in 2025. While the firm adjusted targets on several names, it emphasized a more constructive setup for the sector heading into 2026, particularly for large-cap MedTech, even as Treace remains in a transition phase relative to its larger peers.

Operationally, Treace Medical Concepts, Inc. (NASDAQ:TMCI) continues to deliver steady growth. During the third quarter of 2025, the company reported revenue of $50.2 million, representing 11% year-over-year growth. Management is sharpening its focus on expanding the product portfolio, increasing surgeon education and training, and strengthening the sales organization, initiatives aimed at driving incremental market share gains and improving profitability as procedure volumes normalize.

Founded in 2014 and headquartered in Ponte Vedra, Florida, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a medical technology company dedicated to advancing the standard of care for the surgical treatment of bunion and related midfoot deformities. While near-term investor sentiment remains cautious, the company’s continued revenue growth and strategic investments in commercial execution position it to benefit from an improving MedTech demand backdrop as 2026 unfolds.

Page 2 of 10